Sovateltide (PMZ-1620)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sovateltide (PMZ-1620), covering 2025-05-12 to 2025-05-12. Get the full timeline:
Most recent: Clinical Trial Update: PMZ-1620 (Sovateltide) in Acute Ischemic Stroke Patients [Phase 2]